Results 81 to 90 of about 14,712 (219)

Clostridium difficile PCR Ribotypes in Calves, Canada

open access: yesEmerging Infectious Diseases, 2006
We investigated Clostridium difficile in calves and the similarity between bovine and human C. difficile PCR ribotypes by conducting a case-control study of calves from 102 dairy farms in Canada.
Alexander Rodriguez-Palacios   +7 more
doaj   +1 more source

Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens

open access: yesSmall, EarlyView.
This review explores the potential of antimicrobial peptides (AMPs) and nanotechnology for the treatment of gastrointestinal infections. It analyzes bacterial resistance mechanisms, the antimicrobial actions of AMPs, and advances in nanocarriers, such as lipid‐based, polymeric, metallic, and mesoporous silica systems, that enhance peptide protection ...
Christian Shleider Carnero Canales   +10 more
wiley   +1 more source

Fluoroquinolones in ambulatory surgical practice: whom, when, how?

open access: yesАмбулаторная хирургия, 2016
The articLe discusses the indications and conditions for the use of fLuoroquinoLones (ciprofloxacin, LevofLoxacin, moxifLoxacin) in surgicaL infections of the skin and soft tissues in ambuLatory patients.
A. V. Golub   +2 more
doaj  

Antibiotic Resistance in Salmonella Typhimurium Isolates Recovered From the Food Chain Through National Antimicrobial Resistance Monitoring System Between 1996 and 2016

open access: yesFrontiers in Microbiology, 2019
Salmonella is a major foodborne pathogen which causes widespread contamination and infection worldwide. Salmonella Typhimurium is one of the leading serovars responsible for human and animal salmonellosis, globally.
Xuchu Wang   +9 more
doaj   +1 more source

Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections

open access: yesSmall Science, EarlyView.
This review critically evaluates fluorescent antibiotics as promising agents combining diagnostic precision with therapeutic efficacy. It highlights advances in probe design, chemical conjugation strategies, real‐time imaging applications, selective pathogen detection, and targeted therapy. The potential to combat antimicrobial resistance is discussed,
Tan Phuoc Ton   +3 more
wiley   +1 more source

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods

open access: yesFrontiers in Pharmacology, 2019
According to the updated Roussel Uclaf Causality Assessment Method (RUCAM), drug-induced liver injury (DILI) is currently defined based on thresholds of alanine aminotransferase (ALT) levels above 5 × the upper limit of normal (ULN) and/or alkaline ...
Hongyi Yang   +6 more
doaj   +1 more source

Revolutionising Antibacterial Warfare: Machine Learning and Molecular Dynamics Unveiling Potential Gram-Negative Bacteria Inhibitors [PDF]

open access: yesarXiv
Diseases caused by bacteria have been a threat to human civilisation for centuries. Despite the availability of numerous antibacterial drugs today, bacterial diseases continue to pose life-threatening challenges. The credit for this goes to Gram-Negative bacteria, which have developed multi-drug resistant properties towards \b{eta}-lactams ...
arxiv  

Avoiding early diagnosis

open access: yes
Journal of General and Family Medicine, EarlyView.
Takao Wakabayashi   +5 more
wiley   +1 more source

Hybrid nanosystems for the treatment of infectious diseases produced by multidrug‐resistant bacteria: A systematic review

open access: yesVIEW, EarlyView.
Abstract The rise of multidrug‐resistant (MDR) bacteria poses a significant challenge to effectively treating infectious diseases. In recent years, nanotechnology has emerged as a promising approach to combat MDR bacterial infections. This systematic review, following the research guidelines proposed by PRISMA, aims to provide a comprehensive overview ...
Pegah Tabatabaei Tabrizi   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy